World's Best Scientists 2026 revealed!
Jonathan M. Schapiro

Jonathan M. Schapiro

D-Index & Metrics

Microbiology

D-Index
55
Citations
15777
World Ranking
3770
National Ranking
20

Jonathan M. Schapiro publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Jonathan M. Schapiro sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 132 publications — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Jonathan M. Schapiro D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Jonathan M. Schapiro sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 55 D-Index — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Jonathan M. Schapiro is affiliated with Sheba Medical Center in Israel. Their research primarily focuses on the fields of Medicine and Immunology and Microbiology, with significant contributions in Infectious Diseases, Virology, Epidemiology, Hepatology, and Hematology.

The main topics covered by their work include:

  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • Hepatitis C virus research
  • Hepatitis B Virus Studies
  • Hemophilia Treatment and Research
  • Pneumocystis jirovecii pneumonia detection and treatment

Jonathan M. Schapiro has published numerous papers in various peer-reviewed journals. Some of the recent papers include:

  • Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis, 2021, AIDS
  • Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment: Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic Failure, 2023, Clinical Infectious Diseases
  • Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study, 2023, The Lancet HIV
  • Emicizumab prophylaxis in haemophilia patients older than 50 years with cardiovascular risk factors: Real-world data, 2021, Haemophilia
  • Opening the door on entry inhibitors in HIV: Redefining the use of entry inhibitors in heavily treatment experienced and treatment-limited individuals living with HIV, 2022, HIV Medicine

Frequent publication venues where Jonathan M. Schapiro's work appears include:

  • Clinical Infectious Diseases
  • The Lancet HIV
  • AIDS
  • Haemophilia
  • Journal of Antimicrobial Chemotherapy

Throughout their career, they have collaborated frequently with other researchers. Notable co-authors include:

  • Daniel R. Kuritzkes
  • Robert W. Shafer
  • Michael R. Jordan
  • Roger Paredes
  • Ravindra K. Gupta

Best Publications

  • Update of the Drug Resistance Mutations in HIV-1.

    Victoria A Johnson;Francoise Brun-Vezinet;Bonaventura Clotet;Huldrych F Gunthard

  • Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

    Diane E. Bennett;Ricardo J. Camacho;Dan Otelea;Daniel R. Kuritzkes

  • Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial

    J. Durant;P. Clevenbergh;P. Halfon;P. Delgiudice

  • Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel

    Martin S. Hirsch;Huldrych F. Günthard;Jonathan M. Schapiro;Francoise Brun-Vezinet

  • Update of the Drug Resistance Mutations in HIV-1: 2005.

    Victoria A. Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  • HIV-1 drug resistance mutations: an updated framework for the second decade of HAART.

    Robert W. Shafer;Jonathan M. Schapiro

  • Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.

    Cristina Tural;Lidia Ruiz;Christopher Holtzer;Jonathan Schapiro

  • HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance.

    Robert W. Shafer;Soo-Yon Rhee;Deenan Pillay;Veronica Miller

  • Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration

    Rami Kantor;David A Katzenstein;Brad Efron;Ana Patricia Carvalho

  • A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors.

    Bluma Brenner;Dan Turner;Maureen Oliveira;Daniela Moisi

  • Drug Resistance Mutations in HIV-1.

    Victoria A. Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  • The Effect of High-Dose Saquinavir on Viral Load and CD4+ T-Cell Counts in HIV-Infected Patients

    Jonathan M. Schapiro;Mark A. Winters;Fran Stewart;Bradley Efron

  • Frequency of Class I HLA-Restricted Anti-HIV CD8+ T Cells in Individuals Receiving Highly Active Antiretroviral Therapy (HAART)

    Clive M. Gray;Jody Lawrence;Jonathan M. Schapiro;John D. Altman;John D. Altman

  • European guidelines on the clinical management of HIV-1 tropism testing

    L.P.R. Vandekerckhove;Annemarie Wensing;Rolf Kaiser;F. Brun-Vézinet

  • Patient compliance and drug failure in protease inhibitor monotherapy.

    Geertrui F. Vanhove;Jonathan M. Schapiro;Mark A. Winters;Thomas C. Merigan

  • Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study.

    J Durant;P Clevenbergh;R Garraffo;P Halfon

  • Update of the drug resistance mutations in HIV-1: 2007.

    Victoria A Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Huldrych F Günthard

  • Update of the drug resistance mutations in HIV-1: December 2010.

    Victoria A Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Huldrych F Günthard

  • Update of the drug resistance mutations in HIV-1: Fall 2006.

    Victoria A Johnson;Francoise Brun-Vezinet;Bonaventura Clotet;Daniel R Kuritzkes

  • Update of the drug resistance mutations in HIV-1: Fall 2005.

    Victoria A. Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  • Update of the drug resistance mutations in HIV-1: December 2009.

    Victoria A Johnson;Francoise Brun-Vezinet;Bonaventura Clotet;Huldrych F Gunthard

Frequent Co-Authors

Robert W. Shafer
Robert W. Shafer Stanford University
Anne-Mieke Vandamme
Anne-Mieke Vandamme Rega Institute for Medical Research
Daniel R. Kuritzkes
Daniel R. Kuritzkes Brigham and Women's Hospital
Deenan Pillay
Deenan Pillay University College London
Charles A. Boucher
Charles A. Boucher Erasmus University Rotterdam
David Katzenstein
David Katzenstein Stanford University
Françoise Brun-Vézinet
Françoise Brun-Vézinet Université Paris Cité
Douglas D. Richman
Douglas D. Richman University of California, San Diego
Thomas C. Merigan
Thomas C. Merigan Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to a variety of career pathways, including healthcare, research, and information management. For those seeking flexible education options, exploring the best degrees for felons can be encouraging, as some online programs offer accessible routes for individuals with diverse backgrounds.

Healthcare roles such as a functional medicine np combine a strong knowledge of biology and patient care, enabling graduates to specialize in holistic treatment approaches. Additionally, careers in medical coding, like the certified professional coder, offer valuable positions in healthcare administration, translating complex medical information into standardized codes for efficient billing and records.

Another promising area is health information management, where professionals organize and safeguard patient data. Learning about the health information management job description and salary highlights the demand for experts who ensure compliance and accuracy in medical records systems.

Overall, a microbiology degree paired with specialized online certifications or degrees can lead to dynamic and rewarding careers across multiple sectors.

Best Scientists Citing Jonathan M. Schapiro

Trending Scientists

Recently Published Articles